Antituberculosis-Drugs Induced DRESS: A Multidrug Hypersensitivity or Drug Hypersensitivity Relapse? A Case Report
- 17 July 2023
- journal article
- research article
- Published by SAGE Publications in Hospital Pharmacy
- Vol. 59 (1) , 10-14
Abstract
DRESS related to first-line antituberculosis drugs (ATD) is a challenging diagnosis. With a long-lasting combined treatment of 4-concomitantly administrated drugs, identification of the culprit drug remains difficult and may expose patients to treatment interruption and affect their outcome. A 42-year-old female, treated with isoniazid, rifampicin, pyrazinamide and ethambutol for multifocal tuberculosis, developed, 40 days later, hyperthermia, facial edema, cervical lymphadenopathy and generalized exanthema. Biological test results revealed eosinophilia, atypical lymphocytes, and liver injury. DRESS was suspected, and ATD were withdrawn. As patch tests for the 4 ATD showed negative results, we decided to reintroduce pyrazinamide, ethambutol and rifampicin separately with a 3-day interval. Pyrazinamide and rifampicin were tolerated. However, after receiving ethambutol, she developed fever and generalized rash, with no biological abnormalities. Since ethambutol was claimed to be the culprit drug, isoniazid was added, and 10 hours later, the patient developed fever, facial edema, generalized rash, eosinophilia and liver injury. This clinical and biological pattern resolved 2 weeks later. This report suggests a hypersensitivity relapse to ethambutol after isoniazid-induced DRESS.Keywords
All Related Versions
This publication has 22 references indexed in Scilit:
- Lack of cross-toxicity between isoniazid and ethionamide in severe cutaneous adverse drug reactions: a series of 25 consecutive confirmed casesJournal of Antimicrobial Chemotherapy, 2015
- Skin tests may induce DRESS relapseClinical and Translational Allergy, 2014
- Recurrence of drug‐induced reactions in DRESS patientsJournal of the European Academy of Dermatology and Venereology, 2014
- Drug reaction with eosinophilia and systemic symptoms (DRESS): an original multisystem adverse drug reaction. Results from the prospective RegiSCAR studyBritish Journal of Dermatology, 2013
- A multicentre study to determine the value and safety of drug patch tests for the three main classes of severe cutaneous adverse drug reactionsBritish Journal of Dermatology, 2013
- Les effets indésirables des antituberculeux : épidémiologie, mécanismes et conduite à tenirMedecine Et Maladies Infectieuses, 2007
- Syndrome d’hypersensibilité médicamenteuse ou DRESS (Drug Reaction with Eosinophilia and Systemic Symptoms)Annales de Dermatologie et de Vénéréologie, 2004
- Oral Desensitization To Rifampin And Ethambutol In Mycobacterial DiseaseAmerican Journal of Respiratory and Critical Care Medicine, 1994
- USPHS Tuberculosis Short-Course Chemotherapy Trial 21: Effectiveness, Toxicity, and AcceptabilityAnnals of Internal Medicine, 1990
- A method for estimating the probability of adverse drug reactionsClinical Pharmacology & Therapeutics, 1981